Table II.

Comparisons between subjects with and without arterial stiffness

Variables	With arterial stiffness	Without arterial stiffness
N	37	383
Age [years]	44.3 ±12.7	41.7 ±13.8
Male, n (%)	24 (64.9)	252 (65.8)
Current smoking, n (%)	12 (44.4)*	105 (31.1)
SBP [mm Hg]	132 ±7	129 ±6
DBP [mm Hg]	86 ±3	84 ±4
Heart rate [bpm]	78 ±10	74 ±14
Total cholesterol [mmol/l]	4.8 ±1.1	4.9 ±1.3
Triglyceride [mmol/l]	1.7 ±0.5	1.8 ±0.6
LDL-C [mmol/l]	3.2 ±0.5	3.1 ±0.6
HDL-C [mmol/l]	1.2 ±0.5	1.3 ±0.4
FPG [mmol/l]	5.9 ±0.3	5.8 ±0.4
Creatinine [µmol/l]	75.6 ±12.8	72.1 ±15.6
ALB/Cr ratio [µg/mg]	28.3 ±13.2*	23.1 ±11.4
IVS [mm]	10.9 ±1.6*	10.0 ±1.3
LVPW [mm]	10.7 ±1.4*	9.9 ±1.6
Left ventricular hypertrophy, n (%)	10 (27.0)*	39 (10.2)
Albuminuria, n (%)	8 (21.6)*	28 (7.3)
Dyslipidemia, n (%)	5 (13.5)	47 (12.3)
Aspirin, n (%)	3 (8.1)	30 (7.8)
Statins, n (%)	3 (8.1)	42 (11.0)
cf-PWV [m/s]	10.6 ±0.4*	8.7 ±0.6

SBP – systolic blood pressure, DBP – diastolic blood pressure, LDL-C – low-density lipoprotein cholesterol, HDL-C – high-density lipoprotein cholesterol, FPG – fasting plasma glucose, ALB/Cr – albumin/creatinine, IVS – interventricular septal, LVPW – left ventricular posterior wall, cf-PWV – carotid-femoral pulse wave velocity,

^*P < 0.05 versus without arterial stiffness group.